TM 30510

Drug Profile

TM 30510

Alternative Names: CRTH2 antagonists - 7TM Pharma/Ortho-McNeil/J&J

Latest Information Update: 02 Nov 2011

Price : $50

At a glance

  • Originator 7TM Pharma
  • Developer 7TM Pharma; Ortho-McNeil
  • Class Antiallergics; Antiasthmatics
  • Mechanism of Action Prostaglandin D2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Phase I Allergic rhinitis; Asthma

Most Recent Events

  • 01 Nov 2011 Phase-I clinical trials in Allergic rhinitis in Denmark (PO)
  • 01 Nov 2011 Phase-I clinical trials in Asthma in Denmark (PO)
  • 27 May 2010 Preclinical development is ongoing in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top